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Abstract
The severe shortage of organs combined with increasing
demand for them characterize the outcomes for the kidney
allocation process. Despite the efforts to improve the
allocation of kidneys, notable inefficiencies and unequal
access to available organs persist across patient populations.
The goal of this study is to examine (i) whether the adoption
of a patient-oriented information technology (IT), namely the
patient portals, can mitigate inefficiencies in the allocation of
these scarce resources (kidneys) in general; (ii) whether the
adoption of patient portals magnify or alleviate the disparity
issues around access to transplants. Using a rich dataset of
all the kidney transplant records in the U.S. from 2011 to 2014,
we show that the likelihood that the patient receives deceased
donor transplant at a given point in time increases in the
presence of patient portals. However, the varying impact
of IT across sub-populations may indicate that the efforts to
bridge the digital divide may benefit some groups of patients
at the expense of other groups, leading to further disparities.
1. Introduction
Chronic diseases have become a significant and growing
problem in the U.S. and an increasing economic burden on
the U.S. healthcare system. Chronic diseases are responsible
for about 70% of all deaths in the U.S, and the resulting costs
exceed 86% of the total healthcare spending in the U.S [1].
Due to their increasing burden on the U.S. healthcare system,
experts have examined various ways to lower costs while
also improving care quality. One possible avenue for better
managing chronic diseases is to increase patient involvement.
When patients have the primary responsibility for identifying
and conveying their goals and concerns relevant to the
decision they are facing, i.e., take ownership of the medical
decisions, chronic disease management can be improved [2].
Better patient engagement requires providers to share
relevant information with the patients [3, 4]. With increased
adoption of electronic health record (EHR) systems in clinical
practices, a patient web portal connected to an EHR system is
considered to be an effective technology in providing patients
with access to their own health information. Patient portals
provide patients with a single-point access to a variety of
clinical history data such as doctor visits, lab results, chronic
problems, and medication. It is argued that providing patients
access to such information through a portal can lead to
greater patient engagement especially in chronic diseases
management because (i) chronic care requires continuous
oversight of health condition, (ii) continuity of oversight and
timely action heavily rely on active patient participation, and
(iii) patient can make informed decisions with the help of such
decision aids [3]. However, hard evidence onwhether and how
access to patient portals improves care outcomes is limited [5].
Prior work on the effects of patient portals on medical
decisions does not focus on specific contexts that require
the need for such health IT [5]. To better understand the
mechanisms underlying the effects of the patient portal, it
is necessary to consider conditions where the intervention
(technology adoption) has a possible impact on the decision
making processes. In particular, to evaluate the effectiveness
of patient portals, the focus needs to be on medical decisions
in which patients are more likely to be involved as in the
case of chronic disease management [6]. In this study, we
contribute to our understanding of the impact of patient
portals on care by examining the relationship between the
patient portal adoption and individual patient outcomes in
a unique and relevant research context, i.e., the decisions
pertaining to accepting or rejecting kidney transplantation.
Kidney transplant context is a good testbed for exploring
patient portals’ impact on care outcomes because of the
following reasons. First, unlike many other medical decisions,
kidney transplant patients often have a high degree of
autonomy in choosing treatment options—continue on
dialysis or get transplanted—rather than playing a subordinate
role (to care providers) [7]. Therefore, patients who actively
engage in care delivery can significantly change the course
of treatment and the role of portals is likely to be more
pronounced. Second, the decision to stay on the waiting list
or to get transplanted requires patients to be aware of their
health status and make complex trade-offs [7]. Specifically,
the supply of kidneys is very limited while transplant success
is highly uncertain and depends on patient health condition
and other factors. In effect, patients need to make tough
choices about whether to accept a kidney. As the patients
face tough choices, a portal may become a necessity for
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them as personal health information featured in a patient
portal can be useful for the patient to evaluate benefits/costs
of a treatment option. Third, because patients repeatedly
make these decisions until a successful transplant (about 15
times until transplant occurs), patients’ understanding and
involvement increase over time [8]. Given the potentials of
patient portals for improving patient engagement in kidney
transplant, we are interested in the question, “How does the
provision of health information through patient portals affect
an individual patient’s transplant outcomes?”
We use patients’ waiting time to receive a transplant (time
to transplant) as a care outcome for our main analysis. Time
to transplant is considered as an important efficiency measure
in transplant service because patients’ health deteriorates
over time while they are waiting for a kidney transplant and
a majority of patients cannot receive the treatment in time due
to the limited supply of kidney donations [8, 9, 10]. Hence,
time to transplant is a measure of both the quality and access
performance. In addition to quantifying this outcome measure
for a typical patient, we also examine disparities in the
access to kidney transplant (disparities in time to transplant).
Kidneys have been viewed as scarce national resources due
to their highly limited supply, and providing equal access to
organs to all patients is an important objective to achieve for
policymakers [9, 10]. Since there still exist notable disparities
in waiting time across populations, examining unequal access
to care is an important research subject for policymakers
to study. Considering the uneven diffusion of IT we have
observed for years [11, 12] and the possible differential
impact of patient portals on different patient populations, the
variation in the diffusion of patient portals may or may not
impact existing disparities. Besides waiting time, we also
examine other efficiency measures such as quality of kidneys
received for transplant and patient/kidney survival rates after
receiving a transplant as an extension of our analysis.
2. Background
2.1. Patient Portal
A patient portal is a secure website that allows patients
access to health information that can be linked to EHRs
maintained by care providers [6]. Through a patient portal,
patients can also complete forms, schedule appointments,
refill prescriptions, pay medical bills, send a message to their
providers, and receive educational materials. The features
of patient portals may vary, but most patient portals provide
patients access to obtain their personal health information
such as personal medical history and laboratory test results
[13, 14]. In this study, we focus on the main functionality
of patient portals—access to health information.
The conventional view about providing information
through patient portals is that patients can actively involve
in care process and make more informed decisions, and in
turn, the outcomes would also improve [15, 16]. A study
by [6] describes the mechanisms of patient engagement and
informed decision making with access to health information
through patient portals. First, such access enables patients
and caregivers to engage in the utilization of the information
with accurate and comprehensive insight. Second, readily
accessible electronic records is a critical step toward patient
empowerment since patients are unable to achieve sufficient
levels of desired autonomy and self-efficacy with lack of
adequate information. However, there has been insufficient
evidence that supports the view that patients make more
informed decisions with patient portals [5].
A potential area where patient portals can substantially
improve care outcomes is chronic disease management.
Chronic disease management is a patient-centered disease
care which integrates screening, check-ups, monitoring and
coordinating treatment, and patient education, and requires
high levels of patient involvement in care processes unlike
traditional paternalistic approach [17, 2]. For effective chronic
disease management, engaging patients in care process by
providing better information access is necessary [17, 16].
Therefore, effective use of patient portal would lead to greater
engagement of patients in chronic care process where patients
can have higher levels of autonomy.
2.2. Kidney Allocation Process
A patient seeking deceased donor kidney first registers
at a transplant center. The transplant center then conducts
several tests to obtain immunological information about the
patient. Once the transplant center confirms that the patient is
suitable for transplant, the transplant center places the patient
on a national pool of people waiting for a transplant. This
list of transplant candidates (waitlist) is centrally managed by
United Network of Organ Sharing (UNOS). When a kidney is
donated, organ procurement organization (OPO) procures and
recovers the kidney, and then finds biologically compatible
patients who are registered in the waitlist. The compatible
candidates are then sorted into a queue that ranks the potential
candidates based on UNOS’s kidney allocation policy. The
ranking is given to patients mainly based on accrued waiting
time, blood type compatibility, age, immunological sensitivity
to the kidney, and geographical distance between the donor
and the patient. The system allocates the kidney based on such
ranking. When a candidate receives a kidney offer the patient
should decide within a short period (typically two hours)
whether to accept the offer or wait for another offer. If the
patient rejects the offer, the kidney is offered to lower-ranked
candidates. If no candidate accepts the offer within a few
days (typically 24–36 hours), then the kidney is discarded.1
The waitlist grew substantially from around 60,000 to
around 100,000 patients between 2006 and 2015 primarily due
to the substantial mismatch between supply and demand for
kidneys. On average, only 12,000 deceased donor transplants
are performed in a year and the average waiting time is 3.6
years [18]. Despite the limited supply and the ever-increasing
size of the waiting pool, a patient on average rejects 15 offers
1We refer readers to [10] for more details about the allocation process.
Page 3965
before accepting one and getting transplanted. Typically,
patients reject a kidney offer because they hope to get a
better quality kidney in the future. As a result, a considerable
portion of kidney donations (about 16%) is discarded.
Organ allocation for transplant has received significant
research attention in recent years. Most studies in kidney
allocation focus on designing optimal policies for national
kidney allocation using theoretical models [10]. Several
studies examine the impact of patient decisions in the kidney
allocation [19, 20, 21]. Su and Zenios explore the impact
of patients’ heterogeneity in preference on kidney types
[19] and preference revelation on kidney types [20] in the
allocation process. Ata et al. [21] consider wait-listed patients’
forward-looking behavior to design optimal allocation
policies. These papers take the important aspects of patients’
role in designing a new allocation system. However, our
paper focuses on the impact of an information aid for patients,
patient portals, in outcomes resulting from the existing
allocation policy.
2.3. Expected Impacts of Patient Portals
Decision making about accepting/ rejecting a kidney offer
from a deceased donor depends on many factors that may
change over time, such as a patient’s health status-history,
kidney quality, the composition of the patients on the waitlist
[19, 8]. It has been reported that patients often find it difficult
to make an informed decision on an offer and are reluctant
to consider low- or moderate-quality offers from deceased
donors [22, 23, 24], which partly accounts for the long waiting
time in the transplant process and kidney wastage [8, 24,
23, 25]. Although transplant centers educate the patients
about transplantation at the time of waitlisting, and they
periodically (e.g., on an annual basis) interact with patients
during the waiting period, the relatively long time to transplant
deteriorates the effectiveness of such education efforts. In
addition, a typical patients lack of health awareness remains
a significant concern for an effective transplant allocation.
The adoption of health IT such as patient portals can
help patients make an informed decision by providing
easy access to precise and relevant health information for
patients’ decision making [26, 15]. A recent survey shows
that transplant patients’ demand for information access is
generally high and care practice in transplant shifts toward
patient-centric healthcare where patients have more autonomy
in decision making [7, 22]. In this aspect, information sources
featured by patient portals would serve as information aids for
patients and can affect their decisions to transplant. Providing
better information aids, such as the information access
featured in patient portals, could lead to faster utilization of
donated kidneys [22, 23, 24].
Patient-oriented technology adoption can be effective in
improving health outcomes, particularly among minority
patients who typically have less access to technology
resources. In the U.S., there exist significant disparities in
care outcomes, and health literacy, defined as “the ability to
obtain, process, and understand health information needed to
make appropriate health decisions”, is commonly associated
with healthcare disparities [27]. Most reported interventions
to improve care outcomes in minority groups are directed
at patient education and communication [28]. A study by the
Institute of Medicine reports that the use of well-designed web
portals can facilitate patient communication with healthcare
providers and improve patient access to healthcare services
[29]. Therefore, providing patients access to comprehensive
and relevant health information through a patient portal can
reduce the existing disparities in care outcomes.
On the other hand, however, the adoption of a patient
portal would not necessarily benefit minorities more. As
reported in the digital divide literature, individuals’ access
to IT can be limited due to a variety of factors including
race, age, gender, socio-economic status, or place of residence
[11, 30]. Even among those who already have access, there
can still be a disparity in the value that IT can offer due
to the inequality in individuals’ ability to utilize IT [11].
This inequality leads to disparities in the outcomes from
the IT investments and their use, called ‘digital outcome
divide’ [12]. In the healthcare literature, disparities in patients’
access to or use of IT has been repeatedly reported in various
clinical contexts including transplant [31, 32, 33, 34, 35].
African-American patients register for the use of a web portal
less frequently than other ethnic groups [33], and patients
with a higher education level (college or higher) use a patient
portal more frequently than those with a lower education
level [35]. Health literacy has also been considered as a
factor leading to the digital divide among patients [36]. In the
kidney transplant context, significant disparities in the access
to transplant service already exist [9, 37, 38, 39]. Black, less
educated patients, and low-income patients are less likely to
get wait-listed and tend to have a longer waiting time to receive
a transplant. Therefore, it is also possible that the digital divide
that might exist in the patient population would reinforce the
existing disparities in the access to the transplant service.
3. Data andVariables for TheMainAnalysis
We utilize datasets from two sources—Scientific Registry
of Transplant Recipients (SRTR) Standard Analytic Files
(SAF) and Healthcare Information and Management Systems
Society (HIMSS) database. SRTR SAF includes all transplant
records collected by Organ Procurement Transplantation
Network (OPTN) on solid organ transplant candidates, donors,
and recipients in U.S. since 1987 to the present. Candidate
records contain waitlist status history and status justification
as well as summarized biological profiles of candidates
and histocompatibility results. Transplant records include
transplant center profiles, recipient and donor characteristics.
Pediatric candidates, candidates listed for multi-organs,
candidates listed at multiple-centers are also excluded from
the sample since different allocation policies apply to these
groups. We restrict our observation period from 2011
to 2014 because the priority rules for kidney allocation
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changed after the implementation of Kidney Allocation
System (KAS). Furthermore, SRTR started a semi-annual
transplant program-specific report (PSR) on transplant
activities and transplant performance of each transplant center
in 2010. This report provides useful metrics for managing
memberships in the transplant network and insurance
membership, which might cause center-level variations related
to transplant performance. We exclude transplant centers
which performance was flagged as ‘underperforming’ by PSR
from the sample during the observational period. As a result,
6.4% of observations are excluded from our sample.
Our patient portal data is derived from HIMSS database
that offers a large healthcare IT adoption data including
patient portal adoption at the hospital level. HIMSS database
covers the majority of the U.S. hospitals with membership
of the U.S. healthcare systems. HIMSS database captures
variation in patient portal adoption as it provides hospitals’
adoption status of patient portals as well as key functionalities
featured by portals over time. The functionalities include
(i) personal health records (PHR), (ii) access to medical
test results (test), (iii) billing, (iv) scheduling, and (v)
registration. The first two functionalities are directly related
to the major features of patient portals, patient engagement
and information sharing. PHR provides electronic health
information to patients to help them make informed decisions,
and Test is a functionality that provides patients access to
their lab results [40]. The other functionalities are related
to non-clinical features of patient portals as they support easy
access to administrative process such as paying medical bills,
scheduling an appointment, and registering to hospitals.
We merge the two datasets using CMS certification
numbers and our final dataset includes a total of
42,227 transplant candidates, and 219 transplant centers.
Overall,17.69% received deceased donor transplant, 11.48%
received living donor transplant, 14.38% were removed from
the waiting list due to deteriorating health or death, and
53.31% of patients are censored in our dataset. The average
waiting time to receive deceased donor transplant among the
wait-listed patient is 4.54 years. 12.5 of the patients were
able to access to a patient portal with the key functionalities
(PHR and Test) during the observational period.
To study the impact of patient portals on transplant
decision, we use time to deceased donor transplant as the
dependent variable. Specifically, time to transplant is the
time difference between the date the patient registered to the
waitlist and the date that the patient was removed from the list
due to transplant. If a candidate has multiple removal records
on the waitlist due to temporal changes in the patient’s health
status (such as becoming too sick), only the last event is
considered. The main independent variable is Portal-main
and it is coded on a scale from 0 to 2, which indicates
no portal adoption, portal adoption with PHR, and portal
adoption with both PHR and Test, respectively, in a given
year. We consider PHR as the basic functionality of patient
portals regarding information access while lab test results
(Test) can be performed by a third-party care provider and
may not exist in the transplant center’s data repository.
To control for variations in patient portal features, we use
a binary variable, Portal-add which takes a value of one if
a transplant center adopted a patient portal with any of the
non-clinical features–billing, scheduling, and registration. To
account for alternative variations for the time-to-event, we
use two types of control variables. We include factors related
to individual patients to control for patient-level variations,
following the literature on kidney transplant [41, 42]. We also
include center-level controls, following reports on transplant
centers’ activities [43, 44]. We provide descriptive statistics
in Table 1.
Table 1. Variables
and Definitions - Patient Portal on Time to Transplant
Variable Definition
Dependent variables
Deceased Tx Deceased donor kidney transplant (event of interest)
Living Tx Living donor kidney transplant
Too Sick Worsened health condition or death
Other Other event types for removal including errors, unable to
contact, transplant in another country, etc
Independent variable
Portal-main Availability of the key functionalities (PHR and lab test results)
to a patient through a patient portal in a given year
Controls-Patient
Portal-add Availability of an additional functionality (billing, scheduling,
and registration) to a patient through a patient portal
in a given year
Age Age in years
Blood Type ABO blood type-A (reference), B, AB, O
Gender Biological gender of male or female (reference)
Ethnicity Ethnicity of White (reference), Black, Hispanic and other
Diagnosis Primary cause of ESRD including hypertension (reference),
diabetes, polycystic kidneys, glomerulonephritis, and other
cPRA Calculated panel reactive antibody (%)
Dialysis Accumulated time spent on dialysis in years
Pay Primary source for payment including public (reference)
and other
Education Higher than college degree or not (reference)
Wait-Time Accumulated time spent on the waitlist in years
Controls-Center
Center Type Academic or not (reference)
NofTX20 20 or more transplant surgeries performed at a center
in a given year
Region OPTN 11 service regions grouped into 3 categories
Notes. Age, Dialysis, Wait-Time, N of Tx, and Flag are time-varying
variables. Region 1 includes OPTN region 6 and 8. Region 2 includes OPTN
region 4, 5, and 9. Region 0 (reference) includes the other OPTN regions.
4. Analysis and Results
To study the impact of patient portals on time to transplant,
we use survival analysis models that analyze the time
duration between an entry and exit of a subject and the
effects of covariates on the time duration. Traditionally, the
Kaplan-Meier model or the logit hazard model have been
used for time duration analysis [45, 46, 47]. Kaplan-Meier
curves indicate the proportion of patients who are still being
listed on the waitlist. Logit hazard model examines incidence
probability of an outcome of interest at a given time window
and the hazard function to estimate covariates’ impact on
the incidence probability. However, these models are not
appropriate since their estimates are significantly biased when
observations are censored and there exist one or more events
that remove a subject from the record other than the event
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of our interest, called competing events. In our analysis,
patient removal from the list due to living donor transplant,
bad health conditions, or some administrative errors are such
competing events. To overcome this limitation, we use the
cause-specific hazard model in which hazard function denotes
the instantaneous rate (hazard rate) of occurrence of an event
in subjects who are currently event free. The cause-specific
survival model defines the hazard rate λ(t,x) at time t such
that
λ(t,x)= lim
dt→0
Pr{t≤T <t+dt, J=j | T≥t, x}
dt
holds, where j ∈ {1,2,...,m} represents one of m distinct
type of failure (exit of an subject), T represents time duration,
x represents covariates.
Our regression results using the cause-specific hazard
model are provided in Table 2. We run the regression
with different sets of control variables: model (1) provides
univariate estimation; model (2) provides multivariate
estimation without controlling hospital-level variation; model
(3) provides estimation with full specification. An estimated
hazard ratio (HR) in the table can be interpreted as a relative
likelihood of the event of interest. For instance, if HR is
greater than 1, then it indicates a negative association between
the corresponding variable and the time to transplant (i.e.,
a shorter time to transplant). The cause-specific hazard
model requires proportional hazard rates as an assumption.
We test for this assumption of each model by checking
Schoenfeld residuals and verify that hazard rates do not
change substantially over time (i.e., do not violate the
assumption). We also check martingale residuals to confirm
that the results are not driven by extreme observations.
Our models show that Portal-main is positively associated
with the probability that a patient receives deceased donor
transplant at a given time, regardless of model specification
(models 1-3). Although there is some variation in the point
estimate for Portal-main across models, we do not observe
a systematic pattern to the direction of the variation, and we
find the degree of the variation is small. The results imply that
patients with access to personal health information through
patient portals are more likely to receive a deceased donor
transplant early compared to those without such access. The
impact is greater when a patient portal has both PHR and Test
functionalities as the coefficient of Portal-main is greatest
when the value of Portal-main is 2. This is an interesting
result because the finding suggests that patients benefit more
from advanced information sharing functionalities featured
in a patient portal by receiving a transplant earlier. The
other variable related to patient portals, Portal-add, shows
clear opposite impacts on time to transplant. A possible
explanation for this result is that patients with easier access to
administrative services would have better access to alternative
treatment options such as dialysis, and therefore the merit of
choosing transplant as a treatment option could be reduced. It
is also possible that patients with better access to alternatives
Table 2. Patient Portal and Time to Transplant
Hazard Ratio (Standard Error)
(1) (2) (3)
Portal-main
PHR 1.157*** (.062) 1.188*** (.065) 1.151** (.065)
PHR & Test 1.206*** (.045) 1.200*** (.045) 1.195*** (.046)
Portal-add 0.633*** (.017) 0.690*** (.020) 0.688*** (.021)
Age 0.992*** (.001) 0.992*** (.001)
Blood Type
B 0.753*** (.032) 0.765*** (.032)
O 0.811*** (.025) 0.819*** (.025)
AB 0.989 (.082) 0.989 (.082)
Gender 0.934** (.026) 0.930** (.026)
Ethnicity
Black 1.076** (.037) 1.091*** (.038)
Hispanic 0.947 (.038) 1.089*** (.048)
Other 0.997 (.050) 1.083*** (.056)
Diagnosis
Diabetes 0.846*** (.031) 0.733*** (.030)
Polycystic Kidneys 1.170*** (.071) 0.733*** (.072)
Glomerulonephritis 1.171** (.073) 0.733** (.071)
Other 1.206*** (.038) 1.023 (.038)
cPRA 0.515*** (.020) 0.516*** (.020)
Dialysis 1.009** (.005) 1.006 (.005)
Public Insurance 0.948* (.027) 0.952* (.027)
Education 1.054* (.029) 1.059** (.029)
Wait-Time 0.914*** (.007) 0.931*** (.007)
Center Type 0.906*** (.027)
NofTx20 1.271*** (.038)
Region
1 1.413*** (.069)
2 0.741*** (.025)
Chi-squared 283.38*** 1,084.820*** 1,313.35***
Likelihood -58,137.288 -58,024.226 -58,024.226
Observations 42,227 42,227 42,227
Notes. Standard errors are provided in parentheses. Robust standard errors
are used. * p<0.05, ** p<0.01, *** p<0.001. Log-Pseudolikelihood is
reported.
would remain healthier while waiting for transplantation (e.g.,
because they have better access to care through the scheduling
function) and become conservative on the quality of kidney
being offered, which could prolong the waiting time.
Regarding control variables, we observe consistent results
from the findings in the transplant literature. Patient biological
characteristics and center types are the major factors that
predict time to transplant. The cPRA score has the most
significant and greatest impact on the time to transplant.
A 1% increase in cPRA score reduces the hazard rate by
48.5%. This finding is expected since high cPRA implies
a less likelihood of finding a matching kidney from the
national pool. Interestingly, education and public insurance
are also significant predictors. The hazard rate for patients
with a bachelor degree or higher is 5.9% higher than the
hazard rate for patients with a high school degree or lower.
This socioeconomic disparity can possibly be due to the
relationship between patients and hospitals. There might exist
communication barriers between hospitals and patients, and
it would be easier to address the barriers in higher education
groups. Inefficient communication is a strong predictor of
medical non-adherence, and medical non-adherence of a
patient can lead to a period of probation and a temporary
removal of the patient from the waiting list [48]. The hazard
rate for patients with a public insurance as the primary source
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of payment is 6.9% lower than the hazard rate for those with
other payment types. This finding can be explained by the
current Medicare policies for transplant which require a high
copayment rate (about 20%) for immunosuppression and
covers only 36 months after transplantation. Therefore, the
patients would expect a financial burden if they consider
transplant and postpone their decision on transplant [41].
As a robustness check, we consider alternative model
specifications with the following econometric concerns. First,
our current model does not account for time trend in overall
waiting time. The number of wait-listed patients has steadily
increased while the kidney donation has remained consistent
during the observational period [49]. This trend might impact
patients’ decision on a kidney offer because the composition
of the patients on the waitlist also affect a patient’s decision on
a kidney offer. Therefore, it might be reasonable to include an
additional control variable that can account for the time-related
variation. We include a linear time trend as the control in
the cause-specific hazard model and provide the results.
Second, there might exist unobserved heterogeneity that could
create a bias in the results. The unobserved heterogeneity
can be addressed by the inclusion of fixed or random effects
in the models. However, the cause-specific hazard model
does not allow for using fixed effects and allow only for
random effects model called frailty model. We re-estimate
the impact of patient portals by using the frailty model. Third,
subdistribution hazard model introduced by Fine and Gray
(F/G) is another feasible model for survival analysis with
competing events [50]. Although we use the cause-specific
model due to its ease of use and simple implementation,
subdistribution hazard model would be more useful if our
interest is to predict the probability of an event (transplant)
within a period [51]. We run the subdistribution hazard model
with the same set of variables. Forth, we useMeaningful Use
criteria as an alternative measure for the key functionalities
of patient portals. Meaningful Use is an incentive program
governed by CMS and participating providers (hospitals or
physicians). In this program, providers can receive rewards
if they use a CMS-certified health IT and met IT usage
criteria specified in the program. Meaningful Use criteria
require care providers to electronically share personal health
information with their patients upon request, and we expect
Meaningful Use criteria would have a similar impact as the
key functionalities of patient portals. We replace Portal-main
and Portal-add with a new variable,MU, which is coded as
1 if the hospital met MU criteria and 0 otherwise. We report
the regression results with different specifications in Table
3. We find that our findings remain consistent, qualitatively.
Note that our main independent variable measures adoption
of patient portals rather than actual usage of it and we
implicitly assume that patient portals are useful in evaluating
‘complex trade-offs’ required to make the decision on
transplant. We use two approaches to check the impact of
this assumption on our analysis. First, we estimate the impact
of patient portals only on two subsamples—patients whose
cPRA score is greater than 80% and patients whose Estimated
Table 3. Analysis Using Alternative Models
Hazard Ratio (Standard Error)
(1) Time Trend (2) Frailty (3) F/G (4) MU
Portal-main
PHR 1.215*** (.069) 1.172** (.067) 1.149** (.065)
PHR& Test 1.281*** (.050) 1.176*** (.046) 1.200*** (.047)
Portal-add 0.903** (.031) 0.992*** (.001) 0.700*** (.021)
MU 1.751*** (.049)
Patient Controls Yes Yes Yes Yes
Center Controls Yes Yes Yes Yes
Chi-squared 2,160.07*** 1,118.19*** 1,338.91*** 1,518.24***
Likelihood -57,785.579 -57,996.357 -58,586.012 -57,894.88
Observations 42,227 42,227 42,227 42,227
Notes. Standard errors are provided in parentheses. Robust standard errors
are used. * p<0.05, ** p<0.01, *** p<0.001. Log-Pseudolikelihood is
reported.
Post Transplant Survival (EPTS) score is greater than 80%.
The EPTS score measures estimated years of kidney function
after transplant and a high EPTS score implies shorter years
of kidney function after transplant. Patients with a high
cPRA score have a significantly lower chance of getting
a kidney offer by the allocation system and have a longer
waiting time in general. Therefore, patients with a high cPRA
score would more likely to accept a kidney offer immediately
and less likely to consider staying on the waiting list. On
the other hand, however, patients with a high EPTS score
would expect less benefits from receiving transplant unless
a high quality kidney becomes available to them, which may
prolong the waiting time. Second, we replace our dependent
variable, time to deceased donor transplant, with time to living
donor transplant. Living donor transplant yields much better
post-transplant outcomes than deceased donor transplant
and most patients strongly prefer kidney offers from living
donors over kidney offers from deceased donors. Therefore,
since a decision on a living kidney offer does not require
evaluation of the complex ‘trade-offs’, we should not observe
a significant impact of information access features of patient
portals (PHR and Test) in time to living donor transplant.
Our expectations are verified in Table 4. We cannot find any
evidence that contradicts our assumption.
Table 4. Verification of Underlying Assumptions
Hazard Ratio (Standard Error)
(1) cPRA>80% (2) EPTS>80% (3) Living Tx
Portal-main
PHR 1.214 (.178) 1.137 (.135) 0.783 (.188)
PHR& Test 1.166 (.126) 1.073 (.094) 0.918 (.127)
Portal-add 0.704*** (0.056) 0.692*** (.024) 0.824∆ (.021)
Patient Controls Yes Yes Yes
Center Controls Yes Yes Yes
Chi-squared 703.56*** 305.56*** 590.21***
Likelihood -6,337.370 -11,598.49 -4,613.412
Observations 9,707 12,446 42,227
Notes. Standard errors are provided in parentheses. Robust standard errors
are used. ∆ p<0.1, * p<0.05, ** p<0.01, *** p<0.001.
Log-Pseudolikelihood is reported.
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4.1. Stratified
Analysis by Ethnicity and Education
In general, the distribution of IT accessibility and usability
are known to be significantly different for different ethnicity
and socioeconomic groups [52, 12, 30]. This phenomenon
called the ‘Digital Divide,’ has been repeatedly reported by
research studying health IT. The difference in the distribution
of patients’ Internet use and access is attributed to ethnicity
and level of education [32, 31]. Despite the high Internet
accessibility, African-American patients enroll in a patient
portal less frequently than white patients [33, 34], and patients
with a college degree or higher use a patient portal more
frequently than those with a high school degree or lower
[35]. In that sense, the impact of patient portals on transplant
outcomes can vary depending on a patient’s ethnicity and
education status. We test this expectation by performing
stratified analysis with the cause-specific hazard model. We
first analyze by two ethnicity groups, African-American and
other. Then, we analyze by education level, a patient having
a college degree or higher and other.
We report the results from the stratified analysis in Table
5. Column (1a) and (1b) provide the estimation results
for African-American patients and others, respectively.
The impact of patient portals is not significant for
patients with African-American ethnicity while it is
significant for those with other ethnicities. The model
stratification test confirms the validity of this stratified model
(χ2=9.64,df=1,p<0.01). Column (2a) and (2b) provide
the estimation results for patients with a higher education
level (patients with a college degree or higher) and patients
with a lower education level (patients with a high school
degree or lower), respectively. The impact of patient portals
is not significant for patients with African-American ethnicity
when patient portals are equipped only with the basic key
feature, PHR. In contrast, the impact is significant for higher
education group. The model stratification test also confirms
the validity of this stratified model (χ2=5.06,df=1,p<0.1).
To summarize, the results show that the impact of patient
portals on time-to-transplant varies depending on a patient’s
ethnicity and educational status.
Table 5. Stratified Analysis by Ethnicity and Education
Hazard Ratio (Standard Error)
(1a) African (1b) Others (2a) Education (2b) Education
-American Low High
Portal-main
PHR 0.969 (.077) 1.343*** (.107) 1.078 (.069) 1.459** (.171)
PHR & Test 0.998 (.064) 1.305*** (.064) 1.177*** (.051) 1.249** (.111)
Portal-add 0.723*** (.034) 0.678*** (.026) 0.694*** (.023) 0.672*** (.050)
Patient Controls Yes Yes Yes Yes
Center Controls Yes Yes Yes Yes
Chi-squared 737.85*** 747.85*** 926.97*** 406.93***
Likelihood -21,095.941 -32.995.331 -58,586.012 -10.232.53
Observations 16,831 25,446 31,851 10,426
Notes. Standard errors are provided in parentheses. Robust standard errors
are used. * p<0.05, ** p<0.01, *** p<0.001. Log-Pseudolikelihood is
reported.
4.2. Analysis Using Alternative Care Outcomes
In this section, we examine the impact of patient portals
on alternative care outcomes—quality of the kidney accepted
for transplant and the survival rate of a patient after transplant.
Time to transplant is an efficiency measure for transplant
services. The supplemental analysis is worth conducting
because if the reduction in time to transplant is achieved at
the expense of sacrificing the quality of kidney, it indicates
a trade-off patients are facing from the overall process
perspective. Regarding the kidney quality, we use ‘expanded
criteria donor (ECD)’ and ‘kidney donor profile index
(KDPI).’ ECD is a measure for overall quality of a donated
kidney, and a donated kidney is marked as ECD if the donor
is old and/or has more than two risks factors that negatively
affect the recipient’s survival after transplant. KDPI is a newly
introduced measure in 2014 with the change in the allocation
system. KDPI combines a variety of donor factors into a
single number (ranges from 0% to 100%) that summarizes the
likelihood of kidney failure after transplant. We coded KDPI
as 1 if the KDPI score of a kidney is less than 20% (good
quality kidney) and 0 otherwise. We use a 20% threshold
since it is used for the current allocation policies to identify
good quality kidneys.2 For patient/kidney survival rates, we
use 1-year patient mortality rate (PMR) and 1-year kidney
failure rate (KFR) as they are widely used measures for policy
oversight for kidney transplant programs (OPTN, SRTR).
We first run logit regressions to estimate the impact of
patient portals on ECD and KDPI with the same set of control
variables. We then run another set of logit regressions to
estimate the impact of patient portals on PMR and KFR.
The data we use for these regressions is a cross-sectional
data that snapshots all the variables at the time patients exit
from the observation due to deceased-donor transplant. We
use a different set of control variables as some operational
factors are known to affect the survival rates and some of
the variables we used in the previous analysis are known
not affect the survival rates (descriptions not reported due to
space restrictions). We report the regression results in Table
6. Column (1a), (1b), (2a), and (2b) provide the coefficient
of Portal-main on ECD, KDPI, PMR, and KFR, respectively.
We cannot find evidence that patient portal adoption with the
key functionalities has a negative impact on those alternative
care outcomes. We also conducted a stratified analysis to
examine the varying impact of patient portals by ethnicity
and education using the alternative outcomes. The results
of the analysis provide no significant evidence.
5. Discussion and Conclusion
In this paper, we study the role of a patient’s access to
health information featured in a patient portal in the national
kidney allocation process. Our study shows that a patient’s
access to health information featured in a patient portal can
2For further information, we refer readers to
https://optn.transplant.hrsa.gov.
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Table 6. Analysis Using Alternative Care Outcomes
Odd Ratio (Standard Error)
(1a) ECD (2b) KDPI≤20 (2a) PMR (2b) KFR
Portal-main
PHR 1.109 (.148) 0.994 (.108) 0.612 (.194) 1.212 (.315)
PHR & Test 0.927 (.095) 1.271** (.097) 1.334 (.238) 0.983 (.215)
Portal-add -0.036 (.076) -0.104∆ (.058) 0.076 (.164) 0.045 (.160)
Patient Controls Yes Yes Yes Yes
Center Controls Yes Yes Yes Yes
Chi-squared 729.77*** 257.54*** 128.68*** 136.26***
Likelihood -2,782.927 -4.153.325 -914.358 -842.121
Observations 7,744 7,744 7,744 7,744
Notes. Standard errors are provided in parentheses. Robust standard errors
are used. ∆ p<0.1, * p<0.05, ** p<0.01, *** p<0.001.
Log-Pseudolikelihood is reported.
reduce the time to receiving a kidney transplant. This result
can be explained by the impact of information availability in
patients’ likelihood of accepting kidney offers. Our study also
shows that the impact of the information access is limited
or insignificant in some subpopulations where patients tend
to have a longer waiting time, which may imply further
disparities in the transplant service. These findings have
important practical implications at multiple levels: (i) at the
patient level from a chronic disease management perspective,
(ii) at the organizational level from a business efficiency
perspective for a transplant center, and (iii) at the societal
level from a resource allocation perspective. We describe
each perspective next.
First of all, although patient portals tethered to a hospital’s
IT system have been touted for better management of chronic
diseases, there has been little conclusive empirical research to
support the view that patients make more informed decisions
with patient portals and the outcomes would also improve [5].
We believe our research can help in directing future efforts
to improve patient management for chronic diseases by
harnessing the power of patient-oriented health IT. Relative
to other settings used in the existing literature, our research
setting is uniquely positioned to examine the impact of health
IT in chronic disease management because (i) patients can
have high degree of autonomy in making health decisions
related to kidney transplant and (ii) a rich dataset that includes
activities of all transplant patients in the U.S. exists.
Second, management of transplant candidates (or
wait-listed patients) requires substantial effort because
transplant centers need to frequently communicate with
patients, conduct routine medical tests, and educate patients.
With the increasing number of candidates for deceased-donor
kidney transplant, waitlist management becomes a significant
challenge for transplant centers. Failing to manage waitlist
properly can decrease a patient’ chance of receiving a
transplant and increases a patient’ mortality rate while
on the waitlist. A reduced transplant rate and increased
waitlist mortality can significantly deteriorate the financial
soundness of a transplant program. Our findings imply
that patient portal implementation can facilitate the rapid
placement of donated kidneys, improve post-transplant
outcomes, reduce the workload for waitlist management for a
deceased-donor kidney transplant. However, the impacts may
be limited to specific patient groups such as highly educated
or non-African-American patients, which requires transplant
hospitals to customize their strategies when implementing
patient portals as an intervention for improving the patient
management.
Third, since the passage of the National Organ Transplant
Act (NOTA) in 1984, donated kidneys have been viewed as
national resources because of the limited supply of donated
kidneys and the ever-increasing demand for transplants. Any
improvement in the efficiency of allocation would have a
significant impact on social welfare. Our study demonstrates
that patient portals have positive impacts in reducing time
to transplant for deceased-donor transplants while not hurting
other efficiency outcomes. However, since the impact could
vary on subpopulations, the efforts to bridge the digital divide
may benefit some patient groups at the expense of other
groups, leading to further disparities in the care service. Our
analysis of multiple factors provides a more clear picture for
a better policy-making to reduce the existing disparities in
the kidney transplant context. Specifically, policymakers can
utilize our findings on specific functionalities in the patient
portal, patient factors (e.g., education), and post-transplant
outcomes (e.g., graft failure rate) when making adjustments
to policy on kidney allocation system and the federal health
IT policies.
The growing trend of patient portal adoption for chronic
disease management has prompted significant academic
research on the effectiveness of patient portals [5]. However,
few studies have investigated whether patient portals affect
care decisions and outcomes. The conventional view is that
when patients make more informed decisions with the help of
such decision aids, the outcomes would also improve [15, 16].
However, there has been little conclusive empirical research
to support the claim [5]. The implications of the studies on
patient portals typically are limited due to a small sample
size or relatively short observation periods. Therefore, the
evidence about effect of patient portals on patients’ decisions
is insufficient to draw a conclusion as previous studies do
not focus on specific contexts that require the need for such
health IT [5, 6]. We extend the research on patient portals
by examining the relation between the portal intervention
and care outcomes by utilizing a rich panel dataset in a
unique and relevant research context. Also, most of these
studies on patient portals use a binary variable to capture the
portal intervention rather than using a continuous variable (i.e.
different adoption levels), which may underestimate the value
of patient portals. In contrast, our study uses a more granular
measure of adoption by focusing on the key functionalities of
patient portals in evaluating the impact of information access
on care outcomes.
Our study also contributes to the discussion on digital
outcome divide. Digital outcome divide is a goods-centric
view of digital divide and it refers to a disparity in the
value that IT offers due to an uneven diffusion of IT across
individuals at different socioeconomic levels or demographic
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categories [12]. This outcome-dominant perspective is
appropriate when the supply of final goods or services is
highly limited and the even distribution of final goods or
services is required by the society [53]. Because of scarcity
of kidney donation and the ever-increasing size of the demand
pool, donated kidneys haven viewed as national resources.
Therefore, given the different distribution of the value IT
that has been reported in various areas, it is a valid and
meaningful to ask whether bridging the digital divide (portal
adoption) leads to service divide in kidney transplant context.
Our findings on varying impact of patient portals across
populations can extend the digital divide literature to the
societal improvements on service innovation [54].
Our study has a number of limitations and can be extended
in several directions. First of all, our dataset has two
limitations. We cannot observe patients’ actual usage of a
patient portal from our dataset. Also, we cannot observe
individual patients’ history of kidney offers. The use of a
dataset that contains portal usage and offer history would
provide better contextual insights of the value of patient
portals and the mechanisms underlying the effects of patient
portals. Moreover, decisions on portal adoption could be
endogenous, which may overestimate the benefits from
portal adoption by weakening our casual inference. For linear
models, the use of instrumental variables (IVs) or matching
can partially address this identification challenge. However,
IVs and matching approaches are not feasible for most of
traditional survival models for competing events including the
models used in this study. A few recent studies discuss about
the application of the two approaches [55, 56], and we may
address the econometric concern following their suggestions.
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